Literature DB >> 2968326

The influence of medroxyprogesterone acetate (MPA) on hormone parameters in prostatic carcinoma patients.

J Flamm1, J Spona.   

Abstract

In ten patients suffering from previously untreated, advanced, non-metastatic prostatic carcinoma, the effect of MPA on the hormonal parameters of testosterone and luteinizing hormone (LH) was examined. The dosage of MPA amounted to 500 mg i.m. daily for a week. Thereafter 1000 mg i.m. every four weeks were applied. Full castration could be achieved in all patients, and this effect could be kept up during the time of observation. The tolerance was good, there were no side effects.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2968326     DOI: 10.1007/bf02550662

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  17 in total

1.  Endocrine therapy in carcinoma of the prostate gland: 10-year survival studies.

Authors:  J L EMMETT; L F GREENE; A PAPANTONIOU
Journal:  J Urol       Date:  1960-04       Impact factor: 7.450

Review 2.  [Cancer of the prostate].

Authors:  C Bouffioux
Journal:  Acta Urol Belg       Date:  1979-04

3.  [Intra- and extracellular electrolyte concentration of estrogen therapy on patients with carcinoma of the prostate (author's transl)].

Authors:  U Kunze; F Orestano
Journal:  Urologe A       Date:  1973-09       Impact factor: 0.639

4.  The effect of orchiectomy and various doses of stilbestrol on plasma testosterone levels in patients with carcinoma of the prostate.

Authors:  M A Mackler; J P Liberti; M J Smith; W W Koontz; G R Prout
Journal:  Invest Urol       Date:  1972-03

5.  [Palliative treatment of metastasized hypernephroma].

Authors:  K F Klippel; J E Altwein
Journal:  Dtsch Med Wochenschr       Date:  1979-01-05       Impact factor: 0.628

Review 6.  Treatment of advanced cancer of the prostate.

Authors:  G D Chisholm
Journal:  Semin Surg Oncol       Date:  1985

7.  Effect of progestational agents on carcinoma of the prostate.

Authors:  J Geller; B Fruchtman; H Newman; T Roberts; R Silva
Journal:  Cancer Chemother Rep       Date:  1967-02

8.  Response of plasma fibrinogen and plasminogen to hormone treatment and the relation of pretreatment values to mortality in patients with prostatic cancer.

Authors:  U S Seal; R P Doe; D P Byar; D K Corle
Journal:  Cancer       Date:  1976-09       Impact factor: 6.860

9.  Response of serum cholesterol and triglycerides to hormone treatment and the relation of pretreatment values to mortality in patients with prostatic cancer.

Authors:  U S Seal; R P Doe; D P Byar; D K Corle
Journal:  Cancer       Date:  1976-09       Impact factor: 6.860

10.  Effect of hormonal therapy on plasma testosterone levels in prostatic carcinoma.

Authors:  M R Robinson; B S Thomas
Journal:  Br Med J       Date:  1971-11-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.